| Peer-Reviewed

Clinical Representation of the Different Rheumatological Manifestations of Diabetes

Received: 25 March 2022     Accepted: 19 April 2022     Published: 13 January 2023
Views:       Downloads:
Abstract

The various rheumatological clinical manifestations related to diabetes constitute a group of pathologies secondary to diabetes, regardless of the type of diabetes (type 1 or type 2), in most cases the manifestations are discovered at an advanced stage of diabetes, on average after 10 years of evolution. The different conditions of this group are frequent and diverse because they affect the majority of patients followed for diabetes. They are most often unrecognized or under-diagnosed in current practice, due to their clinical presentation which is characterized by a great polymorphism. These different manifestations can affect several structures of the locomotor system (bones, tendons, muscles, nerves or even joints and their synovial membranes) and constitute a real problem of differential diagnosis with the most commonly encountered rheumatological conditions. These clinical manifestations are either directly related to diabetes (chronic sustained hyperglycemia) or indirectly related to the various complications of diabetes; their prevalence is therefore correlated with poor glycemic control and/or the occurrence of other complications of diabetes. In this article, we describe the main rheumatological manifestations, their clinical and paraclinical diagnostic methods, their evolutionary profiles and their prevention as well as the different management in practice, and this will be a reminder in order to improve the practitioner's attitude towards the different clinical presentations of these affections.

Published in International Journal of Clinical and Experimental Medical Sciences (Volume 8, Issue 6)
DOI 10.11648/j.ijcems.20220806.12
Page(s) 87-91
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2023. Published by Science Publishing Group

Keywords

Diabetes, Bone, Joint, Entheses, Muscles, Tendon, Capsule, Hyperostosis

References
[1] Rosenberg S, Fautrel B, De Sauverzac C, Timsit MA. Complications osto articulaires du diabte. Encycl. Med. Chir. (Elsevier, Paris), Endocrinologie Nutrition, 10-366-N-20, 1998, 5.
[2] Montana E, Rozadilla A, Nolla J M, et al. Micro albuminuria is associated with limited joint mobility in type diabetes mellitus. Ann. Rheum. Dis. 1995, 54; 582-586.
[3] Cofer, Diapothèque. Diabète: atteinte de la main, chéiroarthropathie.
[4] Chimenes H, Lequesne M et al. Le minimum diabtologique du rhumatologue. In De Seze S, Ryckewaert A, Khan MF, lactualit rhumatologique 1969, Paris. Expansion Scientifique Publications; 167-172.
[5] Dreiser R L, Khan M F, Vinceneux P. Main diabtique pseudo sclrodermique. In De Seze S, Ryckewaert A, Khan M F, lactualit rhumatologique, 1983, Paris. Expansion Scientifique Franaises 1983; 152-163.
[6] Buckingham B A, Uitto J, Sandborg C, et al. Scleroderma- like changes in insulin- diabetes mellitus clinical and biochemical studies. Diabetes care 1984, 7; 163-169.
[7] Chammas M, Bousquet P, Renard E, et al. Dupuytren diseases, canal tunnel syndrome, trigger finger and diabetes mellitus. J. Hand. Surg. 1995, 20; 109 114.
[8] Kapoor A, Sibbit J, et al. Contractures in diabetes mellitus, the syndrome of limited joint mobility. Semin Arthritis Rheum 1989, 18; 168-180.
[9] T. Dubert. Chirurgie de la main, de l'épaule et du membre supérieur- Chirurgie orthopédique- Microchirurgie, Arthroscopie. Maladie de Dupuytren.
[10] Qiao Q, Keinanen K, Rajala U, et al. Rheumatic pains of previously undiagnosed diabetic subjects. Scand. J. Rheumatol. 1995, 24; 234-237.
[11] Arkkilia P E T, Kantola IM, Viikari J S A et al. Dupuytrens disease in type I diabetic patients: a five-year prospective study. Clin. Exp. Rheum. 1996, 14; 59-65.
[12] Gamstedt A, Holm-Glad J, Ohlson CG, and al. Hand abnormalities are strongly associated with the duration of diabetes mellitus. J. Intern. Med. 1993, 234; 189-193.
[13] Zreik NH, Malik RA, Charalambous CP. Adhesive capsulitis of the shoulder and diabetes: a meta-analysis of prevalence. Muscles. Ligaments and Tendons Journal 2016; 6: 26–34.
[14] Neviaser JS. Arthrography of the shoulder joint: study of the findings in adhesive capsulitis of the shoulder. J Bone Joint Surg 1962; 1321–59. 44A.
[15] Raeissadat SA, Rayegani SM, Langroudi TF, et al. Comparing the accuracy and efficacy of ultrasound-guided versus blind injections of steroid in the glenohumeral joint in patients with shoulder adhesive capsulitis. Clin Rheumatol 2017; 36 (4): 933–40. Apr. Doi: 10.1007.
[16] Fautrel B, Rosenberg S. Complications osto articulaires du diabte. In Andr Grimaldi, Trait de diabtologie. Mdecine- Sciences. Flammarion. 2005; 859-861.
[17] Nguyen A, Jousse-Joulin S, Saraux A. Ténosynovite de De Quervain. Revue du rhumatisme monographies. 2012; 79: 78–84.
[18] Ouédraogo D-D, et al. Manifestations rhumatologiques associéesau diabète sucré chez le sujet noir africain. Médecine des maladies Métaboliques. Novembre 2009; Vol. 3 (5): 520-523.
[19] Asif M. Ilyas, MD. Nonsurgical Treatment for de Quervain's Tenosynovitis. May–June, 2009; 34 (5): 928–929.
[20] Anderson C, et al. Treatment of De Quervain's tenosynovitis with corticosteroids. A prospective study of the response to local injection. Arthritis and rheumatism. 1991; 34: 793-8.
[21] Organisation mondiale de la Santé: Évaluation du risque de fracture et son application au dépistage de l'ostéoporose postménopausique: Rapport d'un groupe d'étude de l'OMS. Genève, World Health Org., 1994 (Tech. Rep. Ser., n° 843).
[22] Revue Dinno santé/Au quotidien, Les spécialistes en parlent tout savoir sur la “diabétoporose” Publié le 31. 08. 2021.
[23] ANDREW J. M. BOULTON. The diabetic foot: a global view. Diabetes Metab Res Rev 2000; 16 Suppl 1: S2-S5.
[24] BLOOMGARDEN et ZACHARY T. American Diabete Association: eo" scientific sessions, 2000: The diabetic foot. Diabetes Care 2000; 24 (5): 946-951.
[25] RAJBHANDARI S. M., JENKINS RC., DAVIES C., et al. Charcot neuroarthropathy in diabetes mellitus. Diabetologia 2002; 45: 1085-1096.
[26] HARTEMANN-HEURTIER A, HA VAN G. and GRIMALDI AThe Charcot Foot. The Lancet, 2002; vol 360, 1776-1779.
[27] OYIBO S. O., JUDE E. B., ALSABBAGH S. M., et al. Le pied diabétique: Evaluation et traitement. Journal des plaies et cicatrisation, 2001; Tome IV n026: 6-10.
[28] SINACORE D. RAcute Charcot neuroarthropathy in patients with diabetes mellitus: healing times by foot location. J Diabetes Complication, 1998; 12 (5): 287-93.
[29] S. Acid. Laura Orioli, Bernard Vandeleene La prise en charge du pied diabétique: de la nécessité d'une équipe pluridisciplinaire. Imed-mars-2017-orioli.
[30] Revue Diabéte66/ le pied de Charcot, pulier le 01/11/2020.
[31] Forestier J., Rotes-Querol J. Senile ankylosing hyperostosis of the spine. Ann Rheum 1950 1950; 9: 321-30.
[32] Taillandier J. Hyperostose vertébrale ankylosante. Revue de rhumatisme 2004; 71; 6: 525-26.
[33] A. Bonnard, DC, M. Wessely, DC, DACBR. La Maladie de Forestier.
[34] B. Mazières. L’hyperostose vertébrale ankylosante (maladie de Forestier et Rotés-Quérol): du nouveau? Revue du rhumatisme 2013; 80 (6): 564-8. J. G. Baños. Hyperostose vertébrale ankylosante. F. Reinaud. Maladie de Forestier et Rotès-Querol ou hyperostose vertébrale engainante / ankylosante. Arthrose en 100 questions. Hyperostose vertébrale ankylosante. Encyclopédie Larousse. L’hyperostose vertébrale ankylosante et vous. Rheuminfo.
[35] Iyer SN, Drake AJ, West RL, et al. Diabetic muscle infarction: a rare complication of long-standing and poorly controlled diabetes mellitus. Case Rep Med 2011; 2011: 407921.
[36] Horton W, Taylor J, Ragland T, Subauste A. Diabetic muscle infarction: a systematic review. BMJ Open Diabetes Res Care 2015; 3: e000082.
[37] Goswami P, Baruah MP The role of MRI in diagnosis of diabetic muscle infarction: an underdiagnosed entity. Int J Endocrinol Metab 2011; 9: 353-5.
[38] Breen JD, Karchmer AW. Staphylococcus aureus infections in diabetic patients. Infect. Dis. Clin. North Am. 1995, 79; 11-24.
[39] Gin H, et al. Infection et diabte. Rev. Med. Int. 1993, 14; 32-38.
Cite This Article
  • APA Style

    Halidou Idrissa Abdoul-Rahamane, Kawtar Nassar, Saadia Janani. (2023). Clinical Representation of the Different Rheumatological Manifestations of Diabetes. International Journal of Clinical and Experimental Medical Sciences, 8(6), 87-91. https://doi.org/10.11648/j.ijcems.20220806.12

    Copy | Download

    ACS Style

    Halidou Idrissa Abdoul-Rahamane; Kawtar Nassar; Saadia Janani. Clinical Representation of the Different Rheumatological Manifestations of Diabetes. Int. J. Clin. Exp. Med. Sci. 2023, 8(6), 87-91. doi: 10.11648/j.ijcems.20220806.12

    Copy | Download

    AMA Style

    Halidou Idrissa Abdoul-Rahamane, Kawtar Nassar, Saadia Janani. Clinical Representation of the Different Rheumatological Manifestations of Diabetes. Int J Clin Exp Med Sci. 2023;8(6):87-91. doi: 10.11648/j.ijcems.20220806.12

    Copy | Download

  • @article{10.11648/j.ijcems.20220806.12,
      author = {Halidou Idrissa Abdoul-Rahamane and Kawtar Nassar and Saadia Janani},
      title = {Clinical Representation of the Different Rheumatological Manifestations of Diabetes},
      journal = {International Journal of Clinical and Experimental Medical Sciences},
      volume = {8},
      number = {6},
      pages = {87-91},
      doi = {10.11648/j.ijcems.20220806.12},
      url = {https://doi.org/10.11648/j.ijcems.20220806.12},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcems.20220806.12},
      abstract = {The various rheumatological clinical manifestations related to diabetes constitute a group of pathologies secondary to diabetes, regardless of the type of diabetes (type 1 or type 2), in most cases the manifestations are discovered at an advanced stage of diabetes, on average after 10 years of evolution. The different conditions of this group are frequent and diverse because they affect the majority of patients followed for diabetes. They are most often unrecognized or under-diagnosed in current practice, due to their clinical presentation which is characterized by a great polymorphism. These different manifestations can affect several structures of the locomotor system (bones, tendons, muscles, nerves or even joints and their synovial membranes) and constitute a real problem of differential diagnosis with the most commonly encountered rheumatological conditions. These clinical manifestations are either directly related to diabetes (chronic sustained hyperglycemia) or indirectly related to the various complications of diabetes; their prevalence is therefore correlated with poor glycemic control and/or the occurrence of other complications of diabetes. In this article, we describe the main rheumatological manifestations, their clinical and paraclinical diagnostic methods, their evolutionary profiles and their prevention as well as the different management in practice, and this will be a reminder in order to improve the practitioner's attitude towards the different clinical presentations of these affections.},
     year = {2023}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Clinical Representation of the Different Rheumatological Manifestations of Diabetes
    AU  - Halidou Idrissa Abdoul-Rahamane
    AU  - Kawtar Nassar
    AU  - Saadia Janani
    Y1  - 2023/01/13
    PY  - 2023
    N1  - https://doi.org/10.11648/j.ijcems.20220806.12
    DO  - 10.11648/j.ijcems.20220806.12
    T2  - International Journal of Clinical and Experimental Medical Sciences
    JF  - International Journal of Clinical and Experimental Medical Sciences
    JO  - International Journal of Clinical and Experimental Medical Sciences
    SP  - 87
    EP  - 91
    PB  - Science Publishing Group
    SN  - 2469-8032
    UR  - https://doi.org/10.11648/j.ijcems.20220806.12
    AB  - The various rheumatological clinical manifestations related to diabetes constitute a group of pathologies secondary to diabetes, regardless of the type of diabetes (type 1 or type 2), in most cases the manifestations are discovered at an advanced stage of diabetes, on average after 10 years of evolution. The different conditions of this group are frequent and diverse because they affect the majority of patients followed for diabetes. They are most often unrecognized or under-diagnosed in current practice, due to their clinical presentation which is characterized by a great polymorphism. These different manifestations can affect several structures of the locomotor system (bones, tendons, muscles, nerves or even joints and their synovial membranes) and constitute a real problem of differential diagnosis with the most commonly encountered rheumatological conditions. These clinical manifestations are either directly related to diabetes (chronic sustained hyperglycemia) or indirectly related to the various complications of diabetes; their prevalence is therefore correlated with poor glycemic control and/or the occurrence of other complications of diabetes. In this article, we describe the main rheumatological manifestations, their clinical and paraclinical diagnostic methods, their evolutionary profiles and their prevention as well as the different management in practice, and this will be a reminder in order to improve the practitioner's attitude towards the different clinical presentations of these affections.
    VL  - 8
    IS  - 6
    ER  - 

    Copy | Download

Author Information
  • Rheumatology Department, Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco

  • Rheumatology Department, Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco

  • Rheumatology Department, Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco

  • Sections